Cardinal Health Inc.
Cardinal Health Q2 FY2026: Double-Digit Revenue Growth and Earnings Beat
Summary
Cardinal Health reported a 19% increase in Q2 FY2026 revenue to $65.6 billion, with GAAP operating earnings up 29% to $707 million and non-GAAP operating earnings rising 38% to $877 million. The company also raised its fiscal 2026 non-GAAP EPS guidance to a range of $10.15 to $10.35, reflecting double-digit segment profit growth across all five operating segments. Cardinal Health completed an annual baseline share repurchase of $750 million and reached its targeted leverage range.
Profitelligence Alerts
Get alerts for CAH
Be first to know when Cardinal Health Inc. files with the SEC.
Filing Categories
Advertisement
About Cardinal Health Inc.
Cardinal Health Inc. is a major global healthcare services and products company, distinguished for providing end-to-end medical solutions. Specializing in healthcare distribution and supply chain management, Cardinal Health serves a comprehensive array of clients including hospitals, pharmacies, and healthcare providers. Notably, the company distributes pharmaceuticals, medical products, and laboratory supplies, ensuring efficient delivery to improve healthcare outcomes. Based in Dublin, Ohio, Cardinal Health plays a pivotal role in enhancing healthcare operational efficiency, offering extensive services like inventory management, logistics optimization, and integrated healthcare solutions that empower providers to focus on patient care. As one of the largest pharmaceutical distributors in the United States, it holds substantial influence in the healthcare sector, pivotal in ensuring the availability of drugs and medical supplies across various platforms, contributing significantly to the healthcare infrastructure worldwide.
Official SEC Documents
Advertisement